Skip to main content

Table 1 Baseline characteristics

From: Effects of metabolic syndrome on aortic pulse wave velocity

Variable MetS(−) group (N = 27) MetS(+) group (N = 32) p-value
Age (yr) 59 ± 11 62 ± 12 0.20
Gender (male) 16 (59.3) 19 (59.4) 0.99
Waist circumference (cm)
 Male 88 ± 7 93 ± 7 0.07
 Female 88 ± 14 88 ± 7 0.96
SBP (mmHg) 124 ± 20 128 ± 14 0.42
DBP (mmHg) 75 ± 7 74 ± 12 0.65
MAP (mmHg) 91 ± 12 93 ± 8 0.37
PP (mmHg) 52 ± 21 53 ± 11 0.85
Central SBP (mmHg) 114 ± 12 117 ± 11 0.47
Central DBP (mmHg) 78 ± 11 77 ± 7 0.73
Central MAP (mmHg) 93 ± 10 94 ± 8 0.77
Central PP (mmHg) 37 ± 14 40 ± 9 0.34
Ankle-brachial index 1.2 ± 0.1 1.1 ± 0.2 0.03
Fasting plasma glucose (mg/dL) 100 ± 8 120 ± 23 <0.01
Hemoglobin A1c (%) 5.8 ± 0.5 6.4 ± 1.3 0.45
Total cholesterol (mg/dL) 179 ± 38 182 ± 44 0.76
Triglyceride (mg/dL) 103 ± 37 184 ± 113 <0.01
High density lipoprotein cholesterol (mg/dL) 49 ± 13 42 ± 11 0.02
Low density lipoprotein cholesterol (mg/dL) 111 ± 34 108 ± 31 0.78
C-reactive protein (mg/L) 1.25 ± 2.09 2.15 ± 2.07 0.06
Framingham risk score 11 ± 5 14 ± 4 <0.01
Pulse wave velocity
 Aorta (m/sec) 7.0 ± 1.4 8.4 ± 1.6 <0.01
 Arm (m/sec) 8.0 ± 1.5 8.8 ± 1.2 0.07
 Leg (m/sec) 9.4 ± 1.4 9.6 ± 1.6 0.68
Augmentation index (%) 78 ± 20 89 ± 25 0.12
Subendocardial viability ratio (%) 122 ± 21 126 ± 30 0.64
Ejection duration (ms) 352 ± 43 337 ± 43 0.30
Right mean IMT (mm) 0.81 ± 0.20 0.94 ± 0.20 0.03
Left mean IMT (mm) 0.79 ± 0.20 0.93 ± 0.20 0.03
  1. Values are presented as mean ± standard deviation or number (%)
  2. MetS(+) positive metabolic syndrome, MetS(−) negative metabolic syndrome, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, PP pulse pressure, IMT intima-media thickness